Plain-English translation of NCT06079021 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing whether a device called CytoSorb can help patients with acute-on-chronic liver failure—a life-threatening condition where damaged livers suddenly get much worse. The device works like a filter to clean your blood and remove harmful substances that cause inflammation. Researchers will compare patients who receive this treatment to patients who only received standard medical care in the past.
When the liver suddenly fails, toxic substances build up in the blood and can damage other organs. This treatment aims to remove those harmful substances more effectively, which could help patients survive and recover better than standard care alone.
You likely qualify if…
You likely don't qualify if…
If you join this study, you would receive the CytoSorb blood-cleaning treatment for 72 hours (3 days) while you're in the intensive care unit. During this time, researchers will monitor your blood levels, measure your muscle strength, and take ultrasound images of your muscles to see how the treatment affects your condition. You may also be assigned to receive one of two different blood-thinning medications as part of your dialysis care, depending on when you enroll.
AI-generated summary from trial data · Aug 19, 2026 · Not medical advice
Belgium
Sponsor
University Hospital, Antwerp
Collaborators
CytoSorbents Europe GmbH
Enrollment target
~20 participants
Started
June 2024
Primary completion
September 2027
Age range
18 Years and older
Last updated on clinicaltrials.gov in May 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Karolien Dams
University Hospital, Antwerp
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.